All manuscripts
Publications TIL Cells G-Rex®100M

SMART G-Rex® & SensoRex™ Technology for In-line, Non-Invasive, and Real-Time Monitoring of TIL Expansion

Published Journal Journal for ImmunoTherapy of Cancer

Share
1 page SMART G-Rex® & SensoRex™ Technology for In-line, Non-Invasive, and Real-Time Monitoring of TIL Expansion

Overview

SMART G-Rex® technology enabled sampling-free tracking of TIL expansion, generating growth curves that reflect both cell growth kinetics and culture quality throughout manufacturing. In the pre-REP, a target of 142 ± 0.5 MHz identified cultures ready for an early harvest yielding 300 to 500 × 10⁶ TIL.

What this paper found

Frequency readings taken through the vessel wall can say when a tumor-infiltrating lymphocyte culture is ready to harvest, without opening it. Both expansion phases of the CTMC platform were followed. First-phase cultures were started in SMART G-Rex®100M-TF from one stage IV melanoma using 5, 10 or 30 tumor fragments, and the Rapid Expansion Protocol was tracked in G-Rex®100M across five lines, with counts extrapolated to G-Rex®500M. In the first phase a reading of 142 ± 0.5 MHz marked cultures that would give 300 to 500 × 10⁶ cells on the same day, a call glucose could not make. In the Rapid Expansion Protocol, 141 ± 0.5 MHz flagged lines a day before plateau, pointing to harvest on Day 10 to 12.

Study details

Authors
Marie-Andrée Forget, Tamara Griffiths, Anindita Ravindran, Aemilia Katzinski, Donastas Sakellariou-Thompson, Siddhartha Arora, Andrew Scheffler, Dan Fick, Jon Pileggi, Chantale Bernatchez
Institution
CTMC, Houston, TX, USA · ScaleReady, New Brighton, MN, USA
Journal
Journal for ImmunoTherapy of Cancer
Year
2026
G-Rex® model(s)
G-Rex®100M
Cell type(s)
TIL Cells
Application area
Solid tumor
Study phase
Preclinical

How G-Rex® was used

First-phase expansion ran in SMART G-Rex®100M-TF vessels, whose built-in sensors are read in line on the SensoRex™ reader, so growth is followed with no sampling and no disturbance to the culture. Three cultures were started from a single stage IV melanoma with 5, 10 or 30 tumor fragments, fed on Day 4 and read daily; the target that came out of them was then used ahead of time on Day 9, on a metastatic head and neck tumor and a second stage IV melanoma, to pick cultures for an early harvest. For the Rapid Expansion Protocol, five TIL lines were activated and expanded in G-Rex®100M beside a six-well G-Rex® plate, one well harvested and counted each day so the count could be extrapolated to the bioreactor, while the SMART G-Rex® itself was read daily.

Explore related

Full citation

Forget MA, Griffiths T, Ravindran A, et al. SMART G-Rex® & SensoRex™ technology for in-line, non-invasive, and real-time monitoring of TIL expansion. J Immunother Cancer. 2026;14(Suppl 2):A385.

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →